Our focus is on companies with proven technologies, differentiated IP, initial commercial traction and significant macro tailwinds supporting their adoption.
Our focus
Companies which can unlock value using the latest developments in hardware, processes and software technologies while improving human and planetary health
Industrial Transition
Our industrial transition investment team is focused on technologies which help reduce industry’s environmental footprint whilst driving returns through cost savings and increased efficiency.
Healthcare
Our healthcare investment team is focused on improving people’s lives through better healthcare outcomes. We identify companies with the most promising innovations in the sector and help them win.
We are Active Partners, Not Just Investors
We have a track record of helping companies solve complex problems as they scale. We take board seats and work alongside founders at every stage. From product to supply chain; from scaling to providing the strategic guidance and hands-on support that companies need to succeed
Technical
know-how
Scientific expertise from some of the top academic institutions.
Industrial connectivity
Deep industrial expertise and connectivity through our network of senior advisers.
Global
reach
Global network of investors and partners with a focus on bridging the UK and Nordics.
Founder
focused
We bring strategic clarity and real operational experience to every investment.
What we look for
We invest in founders who are driving transformative change in industrial transition and healthcare.
Our evaluation criteria are designed to identify companies poised for significant impact and scalable growth:
Exceptional founding teams
We seek teams with deep domain expertise, a track record of execution, and the resilience to navigate complex challenges.
Validated and scalable technology
In cleantech, we focus on hardware innovations that address industrial transitions with proven efficacy. In healthcare, we prioritise medical devices and digital health solutions that have demonstrated clinical validation and scalability.
Robust intellectual property (IP) portfolio
A strong IP strategy is essential for maintaining competitive advantage. We look for companies with well-protected innovations that can withstand market competition and regulatory scrutiny.
Early commercial traction
Evidence of market demand, such as pilot programs, partnerships, or initial sales, indicates a product’s viability. We value early signs of product-market fit and customer engagement.
Impact on human and planetary health
Our investments aim to generate positive outcomes for both people and the planet. In cleantech, this means reducing environmental footprints and promoting sustainability. In healthcare, it involves enhancing patient outcomes and accessibility to care.
Our Investment Approach
Building partnerships with founders begins well before any capital is committed. We like investing the time in getting to know our companies prior to investment as we like to work with them over the long-term, fostering deep alignment and mutual understanding.
Screening
We apply our proprietary filtering criteria to assess opportunities, focusing on investment characteristics that we believe are aligned with company success. These criteria have been established over several years of investing in cleantech and healthcare technologies.
In-depth engagement
We invest time in getting to know companies including undertaking management meetings, site visits, customer calls and engaging with key stakeholders to understand the business’s operations and culture.
Strategic planning
Before investing, we identify areas where our expertise and network can actively contribute to the company’s growth, such as scaling operations, market expansion, regulatory navigation and exit planning.
Long-term partnership and value creation alignment
We ensure clear alignment on long-term strategy and value creation through board participation, milestone setting and providing continuous support by leveraging Namier’s wider platform.
Looking for investment?
Apply for investment by completing our online application form.
Latest investment news
Portfolio Companies
ANB Sensors
Industry disruptive cost effective, smart, self-calibrating, low maintenance pH sensor for use across all sensing platforms, including ocean monitoring and water resource management.
Entrel Access Technologies
Enteral Access Technologies (E.A.T.) has FDA approval for its medical device – DoubleCHEK™. DoubleCHEK™ dramatically reduces the risk of feeding tube misplacement in hospitals. It is positioned to become the gold standard in its class.
Domin Valves
Through transforming hydraulics, Domin creates new solutions – high-speed control valves and ultra-compact pumps – that transform global systems. Domin has resigned hydraulic technology with innovations such as metal 3D printing, modern electronics and advanced design and simulation techniques. Domin addresses the energy efficiency problem while still achieving the performance and precision required by hydraulic systems. This new technology will set a benchmark for years to come.